Barclays analyst, Matthew Bouley, reiterated his Equalweight rating on shares of NCI Building Systems (NYSE: NCS) but cut his price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE